Three things you need to know in the financial markets this morning from investment writer, Tony Cross.
Hollywood Bowl
Full year numbers are out from Hollywood Bowl [LON:BOWL] this morning, with the company understandably having struggled in the wake of COVID-19 restrictions. This covers the period to September 30th and revenues are down almost 40%, although investors may be able to take some solace from the fact that on a like-for-like basis, the number shows some very modest growth. Clearly that’s a subjective view, but keeping with the glass-half-full view, the company also managed to maintain profitability. With 60% of facilities having reopened after the last lockdown, the company sees itself as operating in an agile manner and is optimistic that COVID secure measures plus an ongoing capex commitment will allow them to trade through this.
Oncimmune
Oncimmune [LON:ONC], the AIM-listed global immunodiagnostics company, has this morning announced two deals with the NHS, using its kit to diagnose lung cancers. The company has seen its stock finding favour over the summer off the back of its work in battling COVID, so this news is a timely reminder of the fact this company is working on more than just one project.
Remote Monitored Systems
There’s a very short update out from Remote Monitored Systems [LON:RMS] this morning regarding progress with its recently acquired Pharm 2 Farm business. The company’s new production line for antiviral materials has apparently passed acceptance testing – delays here in recent months had dampened shareholder optimism, so whether today’s news is sufficient to provide reassurance will be interesting to watch.
Sign up for three quick facts and more with our Free Daily Digest newsletter, every weekday morning.
